Merck (MRK) Tops Q4 EPS by 24c

Merck (NYSE: MRK) reported Q4 EPS of $1.80, $0.24 better than the analyst estimate of $1.56. Revenue for the quarter came in at $13.5 billion versus the consensus estimate of $13.46 billion.

GUIDANCE:

Merck sees FY2022 EPS of $7.12-$7.27, versus the consensus of $7.29. Merck sees FY2022 revenue of $56.1-57.6 billion, versus the consensus of $56.64 billion.

For earnings history and earnings-related data on Merck (MRK) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Primoris cuts 2026 outlook on renewables cost overruns, COO exits
• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates